Principal Financial Group Inc. Grows Stock Position in Amedisys, Inc. (NASDAQ:AMED)

Principal Financial Group Inc. grew its holdings in shares of Amedisys, Inc. (NASDAQ:AMED) by 0.4% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 75,388 shares of the health services provider’s stock after purchasing an additional 334 shares during the quarter. Principal Financial Group Inc. owned approximately 0.23% of Amedisys worth $6,983,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB boosted its position in shares of Amedisys by 56.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 120 shares during the last quarter. Fifth Third Bancorp boosted its position in shares of Amedisys by 68.1% during the 1st quarter. Fifth Third Bancorp now owns 348 shares of the health services provider’s stock valued at $32,000 after acquiring an additional 141 shares during the last quarter. UMB Bank n.a. boosted its position in shares of Amedisys by 100.0% during the 1st quarter. UMB Bank n.a. now owns 386 shares of the health services provider’s stock valued at $36,000 after acquiring an additional 193 shares during the last quarter. Johnson Financial Group Inc. bought a new position in shares of Amedisys during the 4th quarter valued at approximately $55,000. Finally, Vestcor Inc bought a new position in shares of Amedisys during the 4th quarter valued at approximately $73,000. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on AMED. Wall Street Zen lowered Amedisys from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 24th. Royal Bank Of Canada restated an “outperform” rating and set a $100.00 price target on shares of Amedisys in a report on Wednesday, April 16th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $100.75.

Amedisys Trading Down 0.3%

Amedisys stock opened at $97.51 on Wednesday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.27. Amedisys, Inc. has a 52 week low of $82.15 and a 52 week high of $98.95. The company has a market capitalization of $3.20 billion, a price-to-earnings ratio of 35.98, a price-to-earnings-growth ratio of 1.33 and a beta of 0.94. The stock has a 50-day moving average price of $95.90 and a 200 day moving average price of $93.61.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.13 by $0.12. The company had revenue of $594.78 million during the quarter, compared to analysts’ expectations of $597.43 million. Amedisys had a return on equity of 12.52% and a net margin of 3.79%. Amedisys’s quarterly revenue was up 4.1% on a year-over-year basis. During the same period last year, the business earned $1.03 earnings per share. Sell-side analysts anticipate that Amedisys, Inc. will post 4.4 EPS for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.